2026.01.06Vol.9 No.1 FDA ICH E2B (R3) ICSR Reporting for the FDA will become a mandatory requirement as of April 1, 2026
2025.12.23Vol.8 No.12 AI Announcement of a press release and technical white paper on the officially registered HPVM patent.
2025.12.13Vol.8 No.9 AI HPVM (AI-PV HiroPharma Validation Method): Official Licensing Program Launched
2025.12.10Vol.8 No.8 AI CIOMS “Artificial Intelligence in Pharmacovigilance (2025)” and HPVM: From Principles to Practical Implementation
2025.11.12Vol.8 No.6 AI HiroPharmaConsulting has received an official "GxP Validation Method for PV System with AI Function (Japanese Patent Application 2024-213393)" from the Japan Patent Office.
2025.10.29Vol.8 No.5 NEWS [HiroPharmaConsulting] On November 1, 2025, HiroPharmaConsulting Co., Ltd. celebrated its fourth(4th) anniversary of incorporation.
2025.09.29Vol.8 No.4 FDA FDA CSA: Computer Software Assurance for Production and Quality System Software, Document issued on September 24, 2025
2025.09.24Vol.8 No.3 AI Reference: Yakuji Nippo News, PV: Pharmacovigilance Special Feature Interview with HiroPharmaConsulting Co., Ltd
